Literature DB >> 12799867

[Differentiation of pain-related and morphine related impairment of cognitive performance and mood in bone marrow transplantation patients].

J Lorenz1, U Baumgärtner, A R Zander, B Bromm.   

Abstract

AIMS: Severe pain of mucositis induced by cytostatic conditioning therapy in bone marrow transplantation (BMT) patients generally requires continuous parenteral opioid treatment. Cognitive and psychological disturbances are frequent complications subsequent to BMT and may result from cerebral opioid side effects. The aim of the study was to evaluate the efficiency of continuous morphine in mucositis pain and the side-effects in BMT patients. Particular emphasis was placed on the question of whether reaction times, which are usually measured to estimate opioid effects upon vigilance, are influenced by pain-induced cognitive impairments in pain patients.
METHODS: While in hospital, 10 BMT patients were examined daily with the aid of a mucositis scale, subjective visual analog scales (VAS) for pain and mood parameters, a German version of the McGill pain questionnaire (MPQ), and a mental performance task battery, and the morphine given was documented. Mental performance tests were simple auditory reaction time and choice reaction time. Seven patients also performed a Sternberg memory search test in which they had to use 'yes' and 'no' response keys to match visually presented test letters to a previously memorized set of letters. Practice and baseline data were collected within the first week before BMT.
RESULTS: The intensity and duration of mucositis differed from patient to patient, resulting in different pain intensities and MPQ scores. Prolongation of the choice reaction time averaged over the period of mucositis treatment correlated significantly with residual pain intensity (Spearman r(s) = 0.88, p < 0.01) but not with morphine dose (r(s) = 0.35, p = 0.33). For the Sternberg memory search test greater correlation coefficients resulted between reaction time and morphine dose (r(s) = 0.86, p = 0.014) than between reaction time and residual pain intensity (r(s) = 0.61, p = 0.15). In turn, pain intensity, unlike morphine dose, was significantly correlated with high scores in the mood parameters for depression, passivity, and tiredness.
CONCLUSIONS: It is concluded that both pain and morphine can impair cognitive performance, but that these mental stressors seem to differ according to qualitative criteria. Whereas pain might slow reaction time by distracting a patient's attention, particularly in low mental demand tasks, morphine could interfere with more specific cognitive processes, such as short-term memory operations, that are required in more complex tasks.

Entities:  

Year:  1996        PMID: 12799867     DOI: 10.1007/s004829600004

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  9 in total

1.  Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids.

Authors:  A Banning; P Sjøgren; F Kaiser
Journal:  Acta Anaesthesiol Scand       Date:  1992-07       Impact factor: 2.105

2.  The cognitive effects of the administration of narcotic analgesics in patients with cancer pain.

Authors:  Eduardo Bruera; Karen Macmillan; John Hanson; Neil R MacDonald
Journal:  Pain       Date:  1989-10       Impact factor: 6.961

3.  [Not Available].

Authors:  B Bromm
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

4.  The German counterpart to McGill Pain Questionnaire.

Authors:  Christoph Stein; Gabriela Mendl
Journal:  Pain       Date:  1988-02       Impact factor: 6.961

5.  [Retard morphine in the long-term therapy of severe tumor pain].

Authors:  M Zenz; M Strumpf; M Tryba; E Röhrs; B Steffmann
Journal:  Dtsch Med Wochenschr       Date:  1989-01-13       Impact factor: 0.628

6.  The McGill Pain Questionnaire: major properties and scoring methods.

Authors:  Ronald Melzack
Journal:  Pain       Date:  1975-09       Impact factor: 6.961

7.  Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients.

Authors:  Paul J Tiseo; Howard T Thaler; Jeanne Lapin; Charles E Inturrisi; Russell K Portenoy; Kathleen M Foley
Journal:  Pain       Date:  1995-04       Impact factor: 6.961

8.  Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation.

Authors:  C A Meyers; M Weitzner; K Byrne; A Valentine; R E Champlin; D Przepiorka
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

9.  Concentration-related effects of morphine on cognition and motor control in human subjects.

Authors:  B Kerr; H Hill; B Coda; M Calogero; C R Chapman; E Hunt; V Buffington; A Mackie
Journal:  Neuropsychopharmacology       Date:  1991-11       Impact factor: 7.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.